Racial characteristics of alopecia areata in the United States - 03/02/20
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background |
Epidemiologic studies on the association between race and alopecia areata (AA) are limited.
Objective |
To characterize racial differences of AA in the United States.
Methods |
Cross-sectional study of self-registered AA patients and noncases in the National Alopecia Areata Registry (NAAR). We evaluated odds of AA and its subtypes for 5 ethnic/racial groups using logistic regression. A sex-stratified analysis and a sensitivity analysis among dermatologist-confirmed cases were also performed.
Results |
We identified 9340 AA patients and 2064 noncases. Compared with whites, African Americans had greater odds of AA (odds ratio, 1.77; 95% confidence interval, 1.37-2.28) and Asians had lower odds (odds ratio, 0.40; 95% confidence interval, 0.32-0.50) of AA. The results were consistent in AA subtypes, dermatologist-confirmed cases, and by sex.
Limitations |
Residual confounding due to limited number of covariates. Recall or recruitment bias not representative of the entire disease spectrum. Also, outcome misclassification was possible because not all AA cases in the registry were confirmed by dermatologists.
Conclusion |
Our findings suggest higher odds of AA in African Americans and lower odds in Asians compared with whites. Future studies examining racial disparity in AA from clinical and genetic perspectives are warranted for a better understanding of the disease pathogenesis.
Le texte complet de cet article est disponible en PDF.Key words : alopecia areata, epidemiology, hair disorders, National Alopecia Areata Registry
Abbreviations used : AA, AAP, AAT, AT, AU, CI, NAAF, NAAR, NHS, NHSII, OR
Plan
Funding sources: None. |
|
Conflicts of interest: Dr Qureshi has received honoraria that have been donated to charity from AbbVie, Amgen, Centers for Disease Control and Prevention, Janssen, Merck, Novartis, Pfizer (consultant), and Amgen (investigator). Dr Qureshi is an investigator for Sanofi/Regeneron with no financial compensation. Drs Lee, Jung, Patel, Thompson, and Cho have no conflicts of interest to report. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?